Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 80.24 USD 0.88%
Market Cap: 31.3B USD
Have any thoughts about
Dexcom Inc?
Write Note

Intrinsic Value

The intrinsic value of one DXCM stock under the Base Case scenario is 44.01 USD. Compared to the current market price of 80.24 USD, Dexcom Inc is Overvalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DXCM Intrinsic Value
44.01 USD
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dexcom Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
DXCM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for DXCM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about DXCM?
Bearish
Neutral
Bullish

Fundamental Analysis

80.24 USD
+0.88%
+0.88%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Dexcom Inc
US
Health Care
Market Cap
31.3B USD
IPO
Apr 14, 2005
Employees
6 300
United States of America
Market Cap
31.3B USD
Industry
Health Care
IPO
Apr 14, 2005
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Dexcom Inc

Provide an overview of the primary business activities
of Dexcom Inc.

What unique competitive advantages
does Dexcom Inc hold over its rivals?

What risks and challenges
does Dexcom Inc face in the near future?

Has there been any significant insider trading activity
in Dexcom Inc recently?

Summarize the latest earnings call
of Dexcom Inc.

What significant events have occurred
in Dexcom Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dexcom Inc.

Provide P/S
for Dexcom Inc.

Provide P/E
for Dexcom Inc.

Provide P/OCF
for Dexcom Inc.

Provide P/FCFE
for Dexcom Inc.

Provide P/B
for Dexcom Inc.

Provide EV/S
for Dexcom Inc.

Provide EV/GP
for Dexcom Inc.

Provide EV/EBITDA
for Dexcom Inc.

Provide EV/EBIT
for Dexcom Inc.

Provide EV/OCF
for Dexcom Inc.

Provide EV/FCFF
for Dexcom Inc.

Provide EV/IC
for Dexcom Inc.

Show me price targets
for Dexcom Inc made by professional analysts.

What are the Revenue projections
for Dexcom Inc?

How accurate were the past Revenue estimates
for Dexcom Inc?

What are the Net Income projections
for Dexcom Inc?

How accurate were the past Net Income estimates
for Dexcom Inc?

What are the EPS projections
for Dexcom Inc?

How accurate were the past EPS estimates
for Dexcom Inc?

What are the EBIT projections
for Dexcom Inc?

How accurate were the past EBIT estimates
for Dexcom Inc?

Compare the revenue forecasts
for Dexcom Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dexcom Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dexcom Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dexcom Inc compared to its peers.

Compare the P/E ratios
of Dexcom Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Dexcom Inc with its peers.

Analyze the financial leverage
of Dexcom Inc compared to its main competitors.

Show all profitability ratios
for Dexcom Inc.

Provide ROE
for Dexcom Inc.

Provide ROA
for Dexcom Inc.

Provide ROIC
for Dexcom Inc.

Provide ROCE
for Dexcom Inc.

Provide Gross Margin
for Dexcom Inc.

Provide Operating Margin
for Dexcom Inc.

Provide Net Margin
for Dexcom Inc.

Provide FCF Margin
for Dexcom Inc.

Show all solvency ratios
for Dexcom Inc.

Provide D/E Ratio
for Dexcom Inc.

Provide D/A Ratio
for Dexcom Inc.

Provide Interest Coverage Ratio
for Dexcom Inc.

Provide Altman Z-Score Ratio
for Dexcom Inc.

Provide Quick Ratio
for Dexcom Inc.

Provide Current Ratio
for Dexcom Inc.

Provide Cash Ratio
for Dexcom Inc.

What is the historical Revenue growth
over the last 5 years for Dexcom Inc?

What is the historical Net Income growth
over the last 5 years for Dexcom Inc?

What is the current Free Cash Flow
of Dexcom Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dexcom Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dexcom Inc

Current Assets 4.3B
Cash & Short-Term Investments 2.5B
Receivables 1B
Other Current Assets 736.8m
Non-Current Assets 2.1B
PP&E 1.4B
Intangibles 130m
Other Non-Current Assets 574.7m
Current Liabilities 1.7B
Accounts Payable 326.6m
Accrued Liabilities 1.4B
Other Current Liabilities 19.7m
Non-Current Liabilities 2.6B
Long-Term Debt 2.5B
Other Non-Current Liabilities 142.5m
Efficiency

Earnings Waterfall
Dexcom Inc

Revenue
4B USD
Cost of Revenue
-1.5B USD
Gross Profit
2.5B USD
Operating Expenses
-1.8B USD
Operating Income
628m USD
Other Expenses
52.8m USD
Net Income
680.8m USD

Free Cash Flow Analysis
Dexcom Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DXCM Profitability Score
Profitability Due Diligence

Dexcom Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Exceptional ROE
62/100
Profitability
Score

Dexcom Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

DXCM Solvency Score
Solvency Due Diligence

Dexcom Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
64/100
Solvency
Score

Dexcom Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 100.36 USD with a low forecast of 75.75 USD and a high forecast of 152.25 USD.

Lowest
Price Target
75.75 USD
6% Downside
Average
Price Target
100.36 USD
25% Upside
Highest
Price Target
152.25 USD
90% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DXCM?

Click here to dive deeper.

Dividends

Dexcom Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DXCM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

DXCM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

DXCM News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one DXCM stock?

The intrinsic value of one DXCM stock under the Base Case scenario is 44.01 USD.

Is DXCM stock undervalued or overvalued?

Compared to the current market price of 80.24 USD, Dexcom Inc is Overvalued by 45%.

Back to Top